Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals), By Stage Type (Adult, Pediatrics), By Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others), By Sales Channel (Online Sales, Retail Sales, Institutional Sales) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast Till 2031. The report offers the value (in USD Billion) for the above segments.

Market Projections (2024-2031):

According to a new report by IMIR Market Research on Global The market for Parenteral Nutrition was valued at approximately USD 7.1 Billion in 2023. Over the course of the forecast period (2024–2031), it is expected to increase at a compound annual growth rate (CAGR) of 6.0%, reaching a valuation of USD 14.48 billion by 2031.

The market is growing due to a number of factors, including shorter hospital stays, a growing preference for parenteral nutrition (PN) over enteral nutrition in patients with COVID-19, the development of technically advanced PN products with barcode assistance, and a decreased risk of infection. Providing individuals with COVID-19 with sufficient nutrition remained a priority for maximizing outcomes, according to the ASPEN20 Virtual Conference. This involved overcoming a number of obstacles during the epidemic, like a scarcity of PN items as a result of a broken supply system.

Furthermore, the rapidly aging population and rising natality incidence, along with the rising prevalence of chronic illnesses, including cancer and malnutrition, are significant impact drivers for market expansion. An important growth driver is anticipated to be rising natality. Parenteral feeding has several advantages, including ease of use, increased stomach blood flow, effective nutrient delivery, and maintenance of muscle catabolism. A greater understanding of these advantages is probably going to contribute to higher product demand. For example, health and social care have been promoted through a number of projects and educational campaigns that focus on diet and health awareness.

Special nutritional care is necessary when giving PN to children and infants who are ill or have medical conditions. Nearly 300,000 EU children are expected to need medical nutrition for their unique medical demands in the early stages of life, which supports growth and development, according to Specialized Nutrition Europe (SNE) estimates. According to the study, around 40% of adult patients who are hospitalized suffer from malnutrition. This condition requires medicinal nutrition to treat, which shortens the patient's time in the hospital. PN encourages global adoption by reducing the danger of infection and underdevelopment even further.

Furthermore, the global use of products is rising due to the rising prevalence of chronic illnesses like cancer. PN assists in the delivery of essential nutrients, which support cancer patients at all stage of their illness—from diagnosis to recovery—by preserving their levels of strength, energy, and hydration. The World Health Organization (WHO) estimates that 8.2 million deaths globally are attributed to cancer annually, or 13.0% of all fatalities. Furthermore, within the next few decades, there is predicted to be a 70.0% increase in the number of new instances of cancer. Therefore, one of the main drivers of market growth is the rising incidence of cancer.

Market Dynamics:

Market Drivers-

Increasing Prevalence of Chronic Diseases and Malnutrition

• The global rise in the prevalence of malnutrition & chronic illnesses. Malnutrition is frequently brought on by chronic illnesses like cancer, digestive problems, and neurological disorders because they increase metabolic demands, decrease oral intake, and limit nutritional absorption. Parenteral food is used to give vital nutrients, vitamins, minerals, and calories intravenously to patients with these diseases because they may have trouble achieving their nutritional needs by oral or enteral feeding alone. Furthermore, the aging population raises the requirement for parenteral nutrition therapy amongst hospitalized patients, ICU (intensive care unit) patients, and people with complicated medical demands. These factors also rise with the frequency of critical illnesses & surgical procedures. The need for parenteral nutrition goods and services is increasing as healthcare systems work to meet the dietary requirements of vulnerable patient populations. This is propelling global expansion and innovation in the intravenous nutrition industry. 

Developments in Parenteral Nutrition Delivery Systems and Formulations

• The continuous improvement of parenteral nutrition formulas and delivery methods with the goal of enhancing therapeutic efficacy & patient outcomes. The creation of customized parenteral nutrition solutions that are suited to the particular nutritional needs of various patient populations, such as young patients, elderly patients, and people with particular medical conditions, has advanced significantly over time. Advanced parenteral nutrition formulas minimize the risk of metabolic problems and nutrient deficits while supporting normal development, tissue repair, and immune function through balanced mixtures of amino acids, fats, carbs, vitamins, and trace elements. Furthermore, improvements in automated inflation technology, closed-system transfer devices, and multi-chamber bags, among other parenteral nutrition delivery techniques, enhance safety, precision, or sterility in the preparation and administration of parenteral nourishment therapies. This reduces the likelihood of unfavourable events brought on by contamination and medication errors. The Parenteral Nutrition Market is growing and becoming more competitive due to the constant evolution of parenteral food formulations as well as delivery systems. These advancements stem from continuous endeavours to enhance patient comfort, maximize nutritional support tactics, and foster higher clinical outcomes in the handling of intricate medical illnesses and malnourishment.

Market Trends-

Personalized Nutrition Solutions and Customized Formulations

• The growing focus on individualized formulas and tailored nutrition strategies. Healthcare practitioners are becoming more conscious of the different dietary needs that patient have based on their years of age, health, & unique metabolic requirements. In order to ensure that patients receive the proper balance of macronutrients, micronutrients that and other crucial components, there is a rising trend towards customizing parenteral nutrition formulations to fit their unique needs. For more accurate and tailored nutritional assistance, customized parenteral nutrition systems consider variables such patient weight, medical history, and underlying diseases. The growth, that intends to improve the lives of patients and lower the risk of problems connected to malnutrition, is in line with the larger trend towards precise medicine.

Focus on Transitioning to Home Parenteral Nutrition (HPN)

• The growing emphasis on moving patients to home nutritional therapy is recognized as the parenteral nutrition market (HPN). Parenteral nutrition was traditionally provided in hospital settings, but the advantages of home-based care are becoming more widely acknowledged for patients who need long-term parenteral feeding assistance. Parenteral nutrition therapy can be safely and successfully administered in a home environment because to developments in technology, patient education, and home care services. The demand of patients for greater autonomy and a better quality of life is in line with this trend. Making the switch to home parenteral nutrition benefits patients by being more convenient and by saving money on medical expenses related to extended hospital stays. Thus, in line with the trend toward patient-centric care & the spread of parenteral nutrition outside of the hospital setting, there is an increasing emphasis on creating and executing complete home parenteral nutrition initiatives and assistance services.

Market Restraining Factors-

High Cost of Parenteral Nutrition Therapy

• Sterile parenteral nourishment solutions must be produced, prepared, and administered using specialist equipment and strict quality control procedures, which raises the cost of manufacture. The expense is further increased by the requirement for qualified medical personnel to supervise the administration and keep an eye on patients receiving parenteral feeding. Parenteral nutrition treatment can therefore be expensive for patients and healthcare systems alike. For particular patient populations, parenteral nourishment may be too expensive, especially in areas with little access to healthcare or insurance. To alleviate the financial limitations related to parenteral nutrition therapy and increase its availability in the healthcare sector, in efforts to cut expenses, increase cost-effectiveness, and investigate substitute, economical solutions are required.

Report Coverage:

The report will cover the qualitative and quantitative data on the global Parenteral Nutrition Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations:

Parenteral Nutrition Market Players Analysis:

• Baxter
• Otsuka Pharmaceutical Factory, Inc.
• Forbes Media LLC
• com
• Vifor Pharma Management Ltd.
• AbbVie Inc. 
• Braun Melsungen AG
• Fresenius SE & Co. KGaA
• Grifols S.A.
• Pfizer, Inc.
• ICU Medical, Inc.
• Anhui Medipharm Co., Ltd.
• aculife
• Servona GmbH

Key Industry Developments:

• In November 2022, The Indian Society for Parenteral and Enteral Nutrition (ISPEN) has approved the web-based application iNutrimon, which guarantees that doctors provide patients recovering in a medical facility with the best possible nutrition.
• In February 2022, Pharmasyntez made an announcement announcing that it is building a plant to produce parenteral nutrition.

Parenteral Nutrition Market Segmentation Analysis:

By Nutrient Type

• Carbohydrates
• Parenteral Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins & Minerals

By Stage Type

• Adult
• Pediatrics

By Indication

• Alzheimer’s, Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

By Sales Channel

• Online Sales
• Retail Sales
• Institutional Sales

The report also helps in understanding Global Parenteral Nutrition Market dynamics, structure by analyzing the market segments, and project the Global Parenteral Nutrition Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Parenteral Nutrition Market make the report investor’s guide.

Global Parenteral Nutrition Market Segmentation Insight:

The market scope is segmented because of by Nutrient Type, by Stage Type, by Indication, by Sales Channel.

By Nutrient Type

Based on the Nutrient Type of the market is segmented into Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals.

The category with the largest proportion, single-dose amino acid solution, accounted for more over 30.9% of all sales in 2022. Both an increase in the use of amino acid solutions and an increase in the volume of solutions that regulators have permitted can be connected to this. Recent developments in amino acid solutions also result in less side effects, which enhances patient outcomes. Numerous one-dose amino acid solutions are available in the market, such as Nirmin (made by Nirlife Pharma) and Aminosyn (manufactured by Hospira, Inc.). Amino acid combinations include both essential and nonessential amino acids.

Therefore, the typical constituent serves as all-inclusive parenteral nourishment for general biological processes. Over the course of the forecast period, the parenteral lipid emulsion segment is expected to grow at the fastest rate. The development of hybrid parenteral lipid emulsions using mixed lipid emulsions of fish oil and then olive oil, the increasing acceptance of parenteral nutrition over enteral nutrition in COVID-19 patients, shorter hospital stays, and a lower risk of infection are the main factors expected to drive the segment growth and increase demand for parenteral lipid emulsions.

By Stage Type

Based on the Stage Type of the market is categorised into Adult, Pediatrics.

The adult market accounted for 87.0% of total revenue in 2022, making it the highest share. The segment growth is supported by an aging adult population and a rise in the prevalence of chronic illnesses in adults, including diabetes, sarcopenia, cancer, and Alzheimer's disease. When PN items are not able to be naturally consumed by the patient, they are often used. The category is anticipated to increase at the fastest rate over the forecast period because pregnant women use more items and need more nutrients—such as iron, fatty acids, amino acids, and vitamins—to provide the growing fetus with enough food.

Severe malnutrition in pregnancy has been associated with perinatal death, intrauterine growth restriction, low birth weight, congenital anomalies, and preterm delivery. Parenteral nutrition is advised for expectant mothers whose nutritional demands are not being satisfied by enteral consumption. Furthermore, fat emulsion is being used by an increasing number of expectant mothers as part of full parenteral feeding. The pediatric category is anticipated to experience profitable growth throughout the course of the forecast period. Parenteral nutrition (PN) is used more often in the first few days of life in preterm neonates because they are less able to accept full enteral nourishment and because it is a generally safe strategy to prevent nutritional deficiency.

Regional Snapshots:

By region, Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. North America accounted for the largest portion of overall revenue in 2022, contributing nearly 41.5% of the total. Its biggest market share is mostly attributable to government and private sector research expenditures in the healthcare sector, technologically advanced medical equipment, and collaborations between the medical device industry, academic institutions, regulatory agencies, and other parties. The high rate of hospital admissions has also been attributed to the region's state-of-the-art healthcare facilities, alluring reimbursement schemes, and advantageous laws, in addition to the rising incidence of numerous chronic illnesses, such as cancer and malnourishment.

The Asia Pacific area is expected to have the fastest CAGR during the projection period. Some of the reasons expected to fuel the growth of the Asia Pacific regional market include the increasing prevalence of chronic illnesses caused by unhealthy eating habits and the growing demand for reasonably priced healthcare. Poverty, ignorance of nutrition, and the region's growing population are all contributing reasons to malnutrition, and they are also the main drivers of the region's increased product demand.

Parenteral Nutrition Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report:

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions:

• How much the global Parenteral Nutrition Market valued?
• Which region has the largest share in 2024 for the global Parenteral Nutrition Market?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of Parenteral Nutrition Market:

• Historic year: 2019-2022
• Base year: 2023
• Forecast: 2024 to 2031
• Representation of Market revenue in USD Million

Parenteral Nutrition Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: